Merck hands over $20M in IBD drug target deal with Flagship's Quotient
Merck hands over $20M in IBD drug target deal with Flagship's Quotient
Body unavailable. Use the original source.
Merck hands over $20M in IBD drug target deal with Flagship's Quotient
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.